What can we learn from the NMC Health collapse?

The collapse of NMC Health has shown us that even a shining FTSE 100 champion can be rotten underneath. We can learn a few things from the scandal.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve seen plenty of company collapses during my years as a private investor. But it’s rare it happens to one that’s made it as far as the FTSE 100. That’s what’s happened to NMC Health (LSE: NMC), and there are lessons to be learned.

At its peak in 2018, NMC Health stock was trading at more than £40 per share. Now on Monday, the end of NMC as a listed company has come, after it requested the cancellation of its shares on the London Stock Exchange.

On 13 April, NMC Health announced it had called in the administrators, under pressure from Abu Dhabi Commercial Bank, to which it owed $1bn. That was a month after trading in the shares had been suspended, at a price of 938p. What are they worth now? I reckon almost certainly zero.

NMC Health in administration

My Motley Fool colleague Edward Sheldon has explained how a company entering administration is bad news for shareholders. The company’s creditors and bondholders are ahead in the queue. And if there’s anything left of its assets once its debts are dealt with, only then might shareholders be left with anything.

I seriously doubt there’ll be anything left, as the scale of NMC Health’s debts is truly shocking. It includes previously undisclosed debt of $4bn, for a total debt pile of more than $6.5bn.

Lesson number one

And here’s one lesson for investors. We might wonder how this can happen to a company regulated by the LSE with a FTSE 100 listing. And we might wonder if LSE auditing regulations are too lax. But the thing is, a company’s auditors are working on the company’s behalf. And unless they find anything glaring, they have to take a lot of what the company says in good faith.

The auditors aren’t being paid by the company to perform an in-depth investigation to look for wrongdoings. So don’t assume that just because a company is in the FTSE 100, its accounts must be squeaky clean.

Shorting NMC Health

It’s different for investigative investors such as Muddy Waters, which essentially pulled the plug on NMC Health in December. Back then, Muddy Waters said it believed NMC had “manipulated its balance sheet to understate debt,” having taken a short position against the firm.

And that leads me to lesson number two. A firm like Muddy Waters has to have a pretty tight case to make such potentially devastating claims. And it has a reputation for first-class investigative skills. In my view, it’s going to be very rare Muddy Waters will get something like this wrong. So the lesson I take is — if Muddy Waters says a company’s bad, run for the hills.

The signs were there

Now we know the scale of the debt understatement, Muddy Waters has been well and truly vindicated. Shareholders who heeded December’s report and sold out saved themselves from total wipeout. And, as it happens, NMC Health chairman BR Shetty and vice-chairman Khalifa Al Muhairi dumped a load of shares in January and February.

So, final lesson. When a company is up to its neck in trouble and key insiders are selling, well, I think you know the rest.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended NMC Health. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could this be the FTSE 100’s best bargain for 2025?

The FTSE 100 is full of cheap stocks but there’s one in particular that our writer believes has the potential…

Read more »

Investing Articles

No Santa rally? As the UK stock market plunges 3%, I’m hunting for bargains

Global stock markets are in turmoil as Christmas approaches but our writer is keen to grab some bargains while prices…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

BP share price to surge by 70% in 12 months!? How realistic is that forecast?

Brand new analyst forecasts predict that the BP share price could rise considerably next year! Should investors consider buying this…

Read more »

Investing Articles

BT share price to double in 2025!? Here are the most up-to-date forecasts

The BT share price is up more than 40% over the last eight months with some analysts predicting it could…

Read more »

Investing Articles

Rolls-Royce share price to hit 850p!? Here are the latest expert projections

Analysts predict the Rolls-Royce share price could surge by another 50% in the next 12 months as free cash flow…

Read more »

Investing Articles

Will NatWest shares beat the FTSE 100 again in 2025? Here’s what the charts say

NatWest shares have left rivals Lloyds and Barclays in the dust in 2024. Stephen Wright looks at whether the stock's…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Could the Lloyds share price crash in 2025?

Lloyds is facing a financial scandal potentially landing the bank with a massive customer compensation bill that could send its…

Read more »

British union jack flag and Parliament house at city of Westminster in the background
Investing Articles

Which UK shares could be takeover targets in 2025?

UK shares have done well this year, but a lot of the big returns have come from companies being acquired.…

Read more »